BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 9693125)

  • 1. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
    Alam N; Saggerson ED
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling.
    Chen S; Ogawa A; Ohneda M; Unger RH; Foster DW; McGarry JD
    Diabetes; 1994 Jul; 43(7):878-83. PubMed ID: 8013751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
    Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle.
    Saha AK; Vavvas D; Kurowski TG; Apazidis A; Witters LA; Shafrir E; Ruderman NB
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E641-8. PubMed ID: 9142886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased hepatic fatty acid oxidation at weaning in the rat is not linked to a variation of malonyl-CoA concentration.
    Decaux JF; Ferré P; Robin D; Robin P; Girard J
    J Biol Chem; 1988 Mar; 263(7):3284-9. PubMed ID: 2893801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.
    Saddik M; Gamble J; Witters LA; Lopaschuk GD
    J Biol Chem; 1993 Dec; 268(34):25836-45. PubMed ID: 7902355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malonyl CoA, long chain fatty acyl CoA and insulin resistance in skeletal muscle.
    Ruderman NB; Dean D
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):295-308. PubMed ID: 10212840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion.
    Prentki M; Vischer S; Glennon MC; Regazzi R; Deeney JT; Corkey BE
    J Biol Chem; 1992 Mar; 267(9):5802-10. PubMed ID: 1556096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
    Onay-Besikci A; Sambandam N
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
    Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.
    Lewandowski ED; Fischer SK; Fasano M; Banke NH; Walker LA; Huqi A; Wang X; Lopaschuk GD; O'Donnell JM
    Circ Res; 2013 Jan; 112(1):57-65. PubMed ID: 22982985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation.
    Kerner J; Minkler PE; Lesnefsky EJ; Hoppel CL
    J Biol Chem; 2014 Apr; 289(14):10223-34. PubMed ID: 24558043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of genes regulating malonyl-CoA in human skeletal muscle.
    Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
    J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
    Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
    J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
    Cha SH; Hu Z; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
    Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
    Winder WW; Holmes BF
    J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of DL-2-bromopalmitoyl-CoA and bromoacetyl-CoA in rat liver and heart mitochondria. Inhibition of carnitine palmitoyltransferase and displacement of [14C]malonyl-CoA from mitochondrial binding sites.
    Edwards MR; Bird MI; Saggerson ED
    Biochem J; 1985 Aug; 230(1):169-79. PubMed ID: 4052034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.
    Båvenholm PN; Pigon J; Saha AK; Ruderman NB; Efendic S
    Diabetes; 2000 Jul; 49(7):1078-83. PubMed ID: 10909961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.